Rossgram, a social network linked to a company whose parent group is deemed extremist and banned in Russia, positions itself as a regional counterpart to Instagram and recently announced plans to raise private investment. A post shared via Telegram reportedly included a link to the company’s message about funding. The development has drawn attention from potential investors curious about the platform’s trajectory and compliance with evolving regulatory landscapes in Russia and abroad.
The founders promise an exceptionally high return, projecting yields in the 850 to 950 percent range within three years. To participate, prospective investors would need to complete an application form hosted on the Rossgram site. The minimum investment threshold is cited as 500,000 rubles, according to the developers. Such figures underline a bold growth narrative aimed at attracting private capital to accelerate product development and user acquisition.
In a statement provided to RBC, the network’s founders, Alexander Zobov and Kirill Fillimonov, indicated current plans to secure investments in 2023 totaling 250 million rubles. The stated purpose for this funding is to expedite product development and broaden the user base, signaling a strategic push to move Rossgram from concept toward a broader market debut.
Rossgram first emerged in discussions during the spring of 2022, yet the project has not formally launched. A beta version of the app has appeared on RuStore, but it remains accessible to a limited user group and offers a restricted feature set. The delayed rollout has sparked questions about feasibility, user adoption, and the practical steps needed to scale a competing social platform in a crowded digital space.
Previously covered by News outlets and tech commentary, Rossgram’s beta demo provided glimpses into how the interface might function and what capabilities could be expected once a wider release occurs. Analysts and observers have focused on the policy framework the platform adopts, the technical barriers it must overcome, and the regulatory context that will shape its growth path in both Russian and international markets.